Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if patients should stop taking their angiotensin
converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) around the time of
their angiogram in order to prevent contrast induced nephropathy (CIN).